DMBT1 and neoplasm: This finding was similar to previous studies (32) where the DMBT1 gene was associated with a lower risk of clinical staging, lymph node metastasis, and pathological type and size of tumor, which have suggested that highly expressed DMBT1 possibly inhibits PTC.